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Abstract
Background: The first step in many cellular signaling processes occurs at various types of receptors in the plasma
membrane. Membrane cholesterol can alter these signaling pathways of living cells. However, the process in which
the interaction of activated receptors is modulated by cholesterol remains unclear.
Methods: In this study, we measured single-molecule optical trajectories of epidermal growth factor receptors
moving in the plasma membranes of two cancerous cell lines and one normal endothelial cell line. A stochastic model
was developed and applied to identify critical information from single-molecule trajectories.
Results: We discovered that unliganded epidermal growth factor receptors may reside nearby cholesterol-riched
regions of the plasma membrane and can move into these lipid domains when subjected to ligand binding. The
amount of membrane cholesterol considerably affects the stability of correlated motion of activated epidermal
growth factor receptors.
Conclusions: Our results provide single-molecule evidence of membrane cholesterol in regulating signaling
receptors. Because the three cell lines used for this study are quite diverse, our results may be useful to shed light on
the mechanism of cholesterol-mediated interaction between activated receptors in live cells.
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Background
Receptor proteins are ubiquitous in the plasmamembrane
of mammalian cells, which transduce information about
cellular environment to intracellular signaling networks
[1–3]. There are approximately 1352 receptor proteins
coded by human genome [4]. The flow of information
through those receptors is critically shaped by receptor
interactions. The diverse cellular processes regulated by
such receptor proteins include cell growth and division,
differentiation, migration, and apoptosis [5]. Receptor
signaling dysregulation is attributed to the pathogenesis
of several diseases [6, 7]. Therefore, understanding the
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interactions, molecular processes and relevant structures
of such signaling receptors is imperative.
Human receptor proteins, including the epidermal
growth factor receptor (EGFR), share a common molec-
ular architecture, consisting of an extracellular bind-
ing domain, a single transmembrane helix, a flexible
juxtamembrane segment, and an intracellular tyrosine
kinase domain [8]. Ligand binding to the extracellular
domains induces conformational reorganization that pro-
motes receptor dimerization, leading to the activation of
the intracellular tyrosine kinase domain. However, con-
clusions about the mechanism of ligand-induced dynamic
recruitment and dimerization of membrane-associated
receptors remains controversial [9]. Conventional steady-
state ensemble approaches cannot be used to address the
stochastic nature of activated receptors that encounter
each other in a highly heterogeneous and fluidic plasma
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membrane. Recent advancements in single-molecule flu-
orescent imaging and tracking have provided further
insights into the behavior of EGFR in vivo [10–12].
For example, Lidke et al. devised a two-color quantum-
dot tracking method to visualize the state-dependent
dimerization processes of human EGFR in living cells
[13]. A hidden Markov model was used to extract the
kinetic parameters of the underlying free, co-confined,
and dimerized states.
Researchers have increasingly determined that lipid
domains rich in glycosphingolipids and cholesterol can
facilitate signaling receptors to form a dimer [13–15].
Because the recruitment mechanism and dynamic clus-
tering of receptors in the hierarchical structure of plasma
membranes are not clearly understood, the existence and
functionality of lipid nanoscale domains on EGFR dimer-
ization remains controversial. A growing body of research
indicates that membrane cholesterol can influence the
organization, stability, and function of membrane pro-
teins including receptors [16–18]. The process by which
this cholesterol modulates membrane proteins remains
unclear.
The plasma membranes of live cells are complex and
highly heterogeneous. Single-molecule tracking had been
successfully used to probe the microscopic environments
and fluctuations faced by receptor proteins in a living cell
[13, 19, 20]. As a receptor protein diffuses in the plasma
membrane, it encounters two types of interactions with its
local environment [9, 21]. Firstly, the receptor protein can
induce a local ordering of the surrounding lipid molecules
via a lipid–protein interaction. Furthermore, confinement
by actin filaments can also be involved. We developed an
energetic model to describe the dynamic diffusion of a
membrane-associated protein in a hierarchical structure
of actin corrals and lipid domains [22]. This model enables
us to identify critical information from single-molecule
trajectories. Specifically, the confinement influences on
EGFRs can be revealed by analyzing the normalized vari-
ance of mean square of diffusion step size of receptor pro-
teins in live HeLa cells [20, 22]. In ref. [20], we focused on
the influence of lipid domains on the diffusion of EGFRs.
However, affinity of liganded EGFR for lipid domains and
requirement of membrane cholesterol have not been ver-
ified on different cell lines. In this study, we employed
single-molecule tracking technique to address the prob-
lem associated with the effect of membrane cholesterol
on receptor-receptor interaction in vivo. Please note that
those data are spatially and temporally coarse-grained
from sampling of real molecule motions. The diffusion
coefficient deduced from the coarse-grained trajectories
can be location-dependent, reflecting the influences from
local barriers [23].
Three cell lines were carefully selected for this study.
HeLa cells, which was derived from cervical cancer
cells and had served as the standard in cellular biology
research. Typically, HeLa cells can express EGFR at a
level of 20,000 per cell [24] and approximately contain
17 μg cholesterol per mg protein [25]. The second cell
line, A431, derived from a human epidermal carcinoma,
is a model system for the study of cancer-associated cel-
lular signaling pathways. A431 cells can express EGFR at
an extremely high level (500,000 per cell) [24] and con-
tain 32 μg cholesterol per mg protein [26]. The third one,
MCF12A, is a non-tumorigenic breast epithelial cell line,
which expresses EGFR normally.
Methods
EGFRs were labeled to display their diffusive motions
in the plasma membranes of live cells. An anti-EGFR
antibody-quantum dot complex was synthesized for
attaching specifically on unliganded EGFRs as a fluores-
cent tag. To label liganded EGFRs, we used fluorescent
epidermal growth factors (EGF) to activate EGFRs and tag
them at the same time. A schematic diagram of native and
liganded EGFRs in the environment of plasma membrane
is described in Fig. 1.
Cell culture and reagents
HeLa and A431 cells were cultured in Dulbecco’s Modi-
fied Eagle’s medium (DMEM) with 10 % (v/v) fetal bovine
serum without phenol red, whereas MCF12A cells were
cultured in a 1:1 mixture of DMEM and Ham’s F12
medium containing 20 ng/mL Human EGF, 0.01 mg/mL
bovine insulin, 500 ng/mL hydrocortisone, and 5 %(v/v)
horse serum. Before the single-molecule live-cell imaging
was performed, the cells were plated in a slide with eight-
well chambers. After a 70–80 % confluence was reached,
HeLa and A431 cells were deprived of serum for 24 h,
whereas MCF12A cells were deprived of serum for 3 h.
To tag EGFRs in the plasma membranes of live cells,
anti-EGFR antibody (Thermo Fisher Scientific, Waltham,
MA, USA) was first biotinylated. The resulting biotiny-
lated anti-EGFRs were conjugated with quantum dots
(Qdot585-streptavidin, Thermo Fisher Scientific). Cells
were incubated in a cell culture containing 10 nM of anti-
EGFR-Qdot585 for 15 min and then washed three times
with phosphate buffered saline (PBS). Fluorescent EGF
(EGF-Qdot585) was synthesized by conjugating biotin-
EGF from Invitrogen to Qdot585-streptavidin in PBS.
To activate EGFRs, cells were incubated in a cell cul-
ture containing 40 ng/mL of EGF-Qdot585. Fluorescent
anti-CD59 antibody was synthesized by biotinylating anti-
CD59 antibody (Sigma-Aldrich, St. Louis, MO, USA) and
then conjugated with Qdot585-streptavidin in PBS. To
label CD59, we followed the same protocol as described
above for labeling EGFR.
In this research, we used two drugs to modify the
amount and spatial distribution of cholesterol in the
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Fig. 1 Schematic diagram of epidermal growth factor receptors (EGFRs) in the environment of plasma membrane. EGF-Qdot585 is a fluorescent
epidermal growth factor (EGF) synthesized by conjugating EGF with a quantum dot Qdot585. Here cholesterol molecules are shown in yellow, the
pink lipids represent the raft lipid species, and the dark green lipids are nonraft lipids
plasma membranes of live cells. The first drug is nystatin,
which can be used to render cholesterol more uniformly
distributed, while keeping the total amount of cholesterol
constant [27]. The second drug is methyl-β-cyclodextrin
(MβCD), which can deplete membrane cholesterol to a
low level [28]. Cells were incubated in their normal growth
medium containing 7.5 mM MβCD for 1 h and then
washed three times with PBS before EGFRs (or CD59)
in the cells were labeled fluorescently. To create a uni-
form cholesterol distribution, cells were incubated in a cell
culture with 10 μg/mL nystatin for 1 h.
Single-molecule optical measurement
The output from a blue (473 nm) solid-state laser was
used to excite quantum dots in live cells. The fluores-
cent signals were collected with a high numerical aperture
(NA) oil immersion objective lensmounted on an inverted
optical microscope (IX-71, Olympus Optical Co., Tokyo,
Japan) and filtered using a 473-nm Raman notch filter.
We then detected the fluorescent signals with an electron-
multiplying charge-coupled device (EMCCD, Cascade II
512, Photometrics Inc., Huntington Beach, CA, USA).
Data analysis
Single-molecule optical trajectories of proteins under
study were recorded for as long as 100 s with a frame
period of τ = 25 ms. Position coordinates of
single-molecule proteins were extracted from a set of
images. A typical EMCCD image of EGFRs in a liv-
ing cell is presented in Fig. 2. The nearest posi-
tions in consecutive frames were connected to form
a single-molecule trajectory by using multiple-target
tracing algorithm [29]. Events of confined diffusion
were extracted from a single-molecule trajectory by
using the confinement quantification procedure [30].
The mean squared displacements (MSD) Rτ 2(t) =[|r(t + τ) − r(t)|2 + |r(t) − r(t − τ)|2] /2 were calculated
from single-molecule trajectories. The localization accu-
racy of our apparatus was approximately 40 nm, implying
an accuracy of 0.002 μm2 for Rτ 2 determination. We
presented a histogram of MSD and normalized variance
V (Rτ 2) = σ 2(Rτ 2)/Rτ 2 in a contour plot; here Rτ 2(t)
can quantify the manner in which a receptor molecule
diffuses in its environment, and V (Rτ 2) can reveal the
nature (deterministic or stochastic) of interaction between
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Fig. 2 An EMCCD image of single-molecule EGFRs in a living cell taken with an exposure time of 25 ms; Three typical trajectories of EGFRs diffusing
in a confined region were extracted from measured trajectories using the confinement quantification procedure [30]
a receptor protein and its environment [22]. An attrac-
tive feature of this plot is that when a molecule repeatedly
visits a membrane domain, the characteristic V (Rτ 2) and
Rτ 2 of the lipid domain is imposed on the trajectories,
resulting in the formation of a peak at the corresponding
position on the plot.
The mathematical foundation of the method had been
detailed in [22]. Here we summarize some key findings
to facilitate further discussion. For molecules under free
diffusion, V (Rτ 2) has a constant value of 2. As a recep-
tor protein diffuses under a strong confinement of actin
corral, V (Rτ 2) can be a large positive value [20]. By con-
trast, V (Rτ 2) of a receptor is reduced to below 2 when
it is confined in a lipid domain. This can be understood
as follows: Actin filaments act as soft potential barri-
ers for the diffusing protein [21, 22, 31]. As membrane
proteins diffuse near an actin filament, the soft poten-
tial barrier may stall the diffusing proteins for a brief
moment, which causes a large variance in the diffusion
step size. Furthermore, the faster the protein diffuses,
the larger the variance is. At the limit of fast diffusion,
V (Rτ 2) can reach a saturated level, depending on the bar-
rier height. Owing to the protein-lipid interaction, we
can view a protein and its nearby ordered lipids as a
dressed protein. For a protein diffusing in a lipid domain,
the faster the protein diffuses, the larger the dressing
effect is. This shall result in a smaller variance of Rτ 2,
and thereby yields smaller V (Rτ 2) for faster diffusing
proteins.
Results
Single-molecule optical trajectories of CD59 reveal the
association with cholesterol-rich lipid domains
Lipid raft domains are rich in cholesterol and glycosph-
ingolipids such as ganglioside GM1 [15]. Previous studies
had reported that CD59 can colocalizes with GM1 lipids
in the plasma membrane of a cell [32, 33]. Here we used
CD59 as a marker for the lipid raft domain.
We analyzed the trajectories of Qdot585-Ab-CD59 in
HeLa cells. The resulting V (Rτ 2)-Rτ 2 contour plot was
presented in Fig. 3. For the native HeLa cells, Fig. 3a dis-
plays four peaks (labeled 1, 2, 3, and 4) at the (Rτ 2,V (Rτ 2))
coordinates of (0.004, 1.6), (0.008, 1.2), (0.015, 1.2), and
(0.028, 1.2), respectively. For the MβCD-treated cells
(see Fig. 3b), the four peaks shift upwards as V (Rτ 2)
approaches the free diffusion limit. This result is consis-
tent with the assumption that CD59 proteins are embed-
ded in lipid raft domains. When membrane cholesterol
is depleted by MβCD, CD59s are released from lipid raft
domains, allowing them to diffuse freely.
Lin et al. BMC Biophysics  (2016) 9:6 Page 5 of 11
Fig. 3 Two-dimensional contour plot on the V(Rτ 2)-Rτ 2 plane for Qdot585-Ab-CD59 diffusing in the plasma membrane of (a) native HeLa cells and
(b) MβCD-pretreated HeLa cells
EGF binding causes EGFRs to translocate into
cholesterol-rich lipid domains.
Equipped with the result of CD59, we moved on to mea-
sure and analyze the trajectories of unliganded EGFRs in
the three cell lines. By grouping the MSDs to an appropri-
ate number of bins, a histogram of MSD can be prepared
(see Fig. 4a). Note that the diffusion coefficient is related
to MSD by D = R2τ (t)/4τ with a frame period of τ =
25 ms. We can identify two groups of diffusing species
in the histogram [20]. The faster group displays a peak
at about 0.8 μm2, attributable to non-confined diffusion.
The slower group has a peak near 0.012 μm2, which
Fig. 4 a, b, c Histograms of mean-square displacements (MSD) and (d, e, f) V(Rτ 2)-Rτ 2 plots of unliganded EGFR (Qdot585-Ab-EGFR) diffusing in the
plasma membrane of (a, d) native cells, (b, e) nystatin-pretreated cells, and (c, f) MβCD-pretreated cells. Trajectories were sampled with a frame
period of τ = 25 ms. Data are shown in red for HeLa cells, green for A431 cells, and blue for MCF12A cells
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can be ascribed to confined diffusion. Unliganded EGFRs
of the two cancerous cell lines (HeLa and A431) prefer
to diffuse in the confined diffusion state. The reverse is
apparent in the normal epithelial MCF-12A cells. The cor-
responding V (Rτ 2)-Rτ 2 plots of unliganded EGFRs in the
confined diffusion state are illustrated in Fig. 4d for HeLa
(Red), A431 (Green), and MCF-12A (Blue), respectively.
The regions colored in black indicate the similarity of the
confined diffusion state in the three cell lines. Two peaks
with V (Rτ 2) values of 3 and 4 occur in the three cell
lines, indicating a strong interaction of EGFR with actin
corrals [22].
When different drug effects on membrane choles-
terol are applied with nystatin and MβCD, cholesterol-
mediated interaction of EGFRs can be investigated. The
results are shown in Fig. 4b and c. For the nystatin-
pretreated cells, the MSD profile of EGFR is similar to
that in native cells. Remarkably in native MCF-12A cells,
the population of unliganded EGFR diffusing in the fast
state is larger, whereas that in the MβCD-treated cells
it becomes smaller. After MβCD treatment the cell line
dependent variations in MSD profiles become smaller
(see Fig. 4c), revealing that the lipid environments of
unliganded EGFRs in the three cell lines are similar
after membrane cholesterol is depleted. All these obser-
vations clearly indicate that the diffusion of unliganded
EGFR is relevant to the amount of membrane cholesterol.
Figure 4e and f display the corresponding V (Rτ 2)-Rτ 2
plots of unliganded EGFR in the cell lines subjected to
different drug treatments. Similar V (Rτ 2)-Rτ 2 values as
those observed in native cells were observed, which is
opposite to that of CD59 presented in Fig. 3. The result
suggests that unliganded EGFR may locate outside of the
cholesterol-rich lipid domains.
Figure 5a depicts the diffusion behavior of liganded
EGFR in the three cell lines. Comparing to the result of
unliganded EGFR shown in Fig. 4a, we found that recep-
tor activation with EGF appears to promote the liganded
EGFR (Qdot585-EGF-EGFR) to diffuse in the fast state.
Figure 5b and c show the effects of nystatin and MβCD
on liganded EGFR. Among the three cell lines, the dif-
fusion behavior of liganded EGFRs in A431 cells is least
sensitive to changes in membrane cholesterol. The MSD
profile of liganded EGFR in native HeLa cells is similar to
that in A431; however, it becomes more similar to that in
MCF-12A after MβCD treatment (Fig. 5c).
Fig. 5 a, b, c Histograms of MSDs and (d, e, f) V(Rτ 2)-Rτ 2 plots of liganded EGFR (Qdot585-EGF-EGFR) diffusing in the plasma membrane of (a, d)
native cells, (b, e) nystatin-pretreated cells, and (c, f) MβCD-pretreated cells. Trajectories were sampled with a frame period of τ=25 ms. Data are
shown in red for HeLa cells, green for A431 cells, and blue for MCF12A cells
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Figure 5d presents the corresponding V (Rτ 2)-Rτ 2 plots
of native cells. Compared to the result of unliganded EGFR
shown in Fig. 4d, EGF binding decreases V (Rτ 2) to below
the free diffusion limit, suggesting that liganded EGFR
may encounter with different environments. The V (Rτ 2)
value of liganded EGFR increases from that in the native
cells (Fig. 5d) to approximately at the free diffusion limit
in the nystatin-pretreated (Fig. 5e) and MβCD-pretreated
cells (Fig. 5f). By contrast, uniformly distributing mem-
brane cholesterol does not change the V (Rτ 2) value of
unliganded EGFR. This finding suggests that liganded
EGFRs may colocalize with membrane cholesterol, but
unliganded EGFRs do not. The V (Rτ 2)-Rτ 2 plots of lig-
anded EGFRs in the three cell lines are similar to that of
CD59, further supporting that these two types of proteins
are located in similar environments. These experimental
results may be effectively explained by the concept that
unliganded EGFRs are located outside the cholesterol-rich
lipid domains and EGF binding causes the receptors to
move into the cholesterol-rich lipid domains [20].
Cholesterol-mediated interaction between liganded EGF
Receptors
When a receptor protein passes a nearby receptor, it may
experience an attractive force that can result in a corre-
lated motion between the two molecules [34]. To quanti-
tatively display the correlation between two trajectories,
we expressed the position vectors as a phasor rk(t) =
Ak(t)ei θk(t) and calculated the degree of correlation with
C(τ ) = Re
⎡
⎢⎣












Thus, we can select highly correlated segments from tra-
jectories by using C >0.8. We analyzed those segments
to disclose the correlated motion of paired Qdot585-EGF-
EGFRs.
Figure 6a displays the MSD histograms of cor-
related Qdot585-EGF-EGFRs in native HeLa (red),
A431(green), and MCF-12A (blue), respectively. The cor-
related Qdot585-EGF-EGFRs in HeLa and A431 cells
appear to diffuse more slowly than the independent
Qdot585-EGF-EGFR does, reflecting an attractive inter-
action effect with their nearby companion. To further
examine the nature of receptor-receptor and receptor-
environment interactions, we subjected those highly cor-
related segments to V (Rτ 2)-Rτ 2 analysis. The resulting
V (Rτ 2)-Rτ 2 plots for the three cell lines are presented
in Fig. 6d. The contour plots are more scattered than
those of independent Qdot585-EGF-EGFRs (see Fig. 5d),
revealing that this data analysis scheme is highly sen-
sitive to receptor interaction. The V (Rτ 2) value of the
correlated Qdot585-EGF-EGFRs is considerably lower
in A431 cells, attributable to highly effective receptor-
lipid and receptor-receptor interactions in A431 cells
[20]. To inspect the nature of interactions and the rele-
vance to receptor-induced lipid ordering, we again took
advantages of the drug effects with nystatin and MβCD.
Figure 6b and c display the MSD histograms of the cor-
related Qdot585-EGF-EGFRs. Pretreatment of HeLa cells
with MβCD shifts the MSD profile of liganded EGFRs
to the side of higher diffusion constant. MβCD treat-
ment also broadens the MSD profile of liganded EGFRs
in A431 cells. The V (Rτ 2)-Rτ 2 plots for the three cell
lines pretreated with nystatin are presented in Fig. 6(e).
Correlated Qdot585-EGF-EGFRs appear to experience a
weaker interaction in the nystatin-treated A431 cells, as
evidenced by an increased V (Rτ 2) value. This observa-
tion may be explained with less stable lipid domain due
to lower amount of cholesterol, resulting in larger vari-
ance of diffusing step size of the correlated receptors.
By contrast, the effective interaction becomes stronger
in nystatin-treated MCF-12A cells, suggesting the effect
of cholesterol-mediated interaction is opposite to that
of receptor-lipid interaction. The V (Rτ 2) of correlated
Qdot585-EGF-EGFR in A431 increases by two orders of
magnitude from 10−2 of native cells to 1 of MβCD treated
cells. Noteworthy, the V (Rτ 2) value can be increased to
higher than 10 in MβCD treated HeLa and MCF-12A
cells, revealing that a deterministic dimerization interac-
tion will dominate after membrane cholesterol is depleted.
These observation results exhibit the vital role of mem-
brane cholesterol in mediating the interaction between
liganded receptors in the three cell lines under study.
Discussion
A receptor protein can induce order in the surround-
ing lipids through the receptor-lipid interaction [22].
The degree of induced lipid order is determined by the
effects of receptor-lipid interaction and the amount of
cholesterol in the plasma membrane. Recent molecular
dynamics (MD) simulations of human receptor tyrosine
kinases in various lipid bilayers revealed that the pre-
dominant drivers of the receptor-induced lipid ordering
domains may originate from electrostatic interactions
between the anionic lipids and clustering basic residues
in the juxtamembrane starting region of receptors [35].
Lipid domains had been predicted to exist in multi-
component membranes and experimentally observed on
artificial membranes. For example, thermal fluctuations
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Fig. 6 a, b, c Histograms of MSDs and (d, e, f) V(Rτ 2)-Rτ 2 plots of correlated Qdot585-EGF-EGFRs diffusing in the plasma membrane of (a, d) native
cells, (b, e) nystatin-pretreated cells, and (c, f) MβCD-pretreated cells. Trajectory segments with a degree of correlation exceeding 0.8 were analyzed.
Trajectories were sampled with a frame period of τ = 25 ms. Data are shown in red for HeLa cells, green for A431 cells, and blue for MCF12A cells
on a multicomponent membrane can produce inhomo-
geneities of lipid phases because the order parameters of
lipid systems depend not only on the lipid composition
but also on the compositional difference of two lipid leaves
[36]. Coupling between inner and outer leaves of an asym-
metric lipid bilayer could also produce inhomogeneities of
lipid phases with a nonzero curvature [37].
In a cholesterol-rich lipid domain, interactions
between receptors may be regulated by membrane
cholesterol. Such cholesterol-mediated interactions
between membrane-associated proteins and cholesterol-
dependent nanoassemblies had been reported in the
literature [16, 38–40]. Recently, coarse-grained MD
simulations had been carried out to explore the nature
of molecular interaction between membrane cholesterol
and β2-adrenergic receptor [41]. This simulation revealed
that cholesterol can bind to transmembrane helix IV of
β2-adrenergic receptor and thereby regulates the dimer
formation. Several experimental studies also showed that
membrane cholesterol can regulate ligand-induced acti-
vation of receptors [16–18]. Affinity of liganded EGFR for
lipid domains and requirement of membrane cholesterol
in those lipid heterogeneities have not been verified.
In this research, we found that unliganded EGFRs may
reside outside cholesterol-rich lipid domains of the
plasma membranes and can move into lipid raft domains
when subjected to ligand binding. Our study provides
single-molecule experimental evidence of membrane
cholesterol in regulating signaling receptors. Noteworthy,
some raftophilic proteins were recently found to appear
preferentially at a spatial proximity (<150 nm) to the
GM1 nanodomains without physical intermixing [40].
It is appealing to improve our understanding for the
mechanism that can drive the ligand bound receptor
to lipid domains. Based on the V (Rτ 2)-Rτ 2 analysis of
single-molecule EGFR trajectories in live cells, we pro-
posed a simple molecular-level model. Ligand binding to
an EGFR can induce a conformational change of EGFR
that may expose some residues with high cholesterol
affinity. Thereby, liganded EGFRs may provoke an aggre-
gate of their neighboring raft lipids (such as GM1) to
form a cholesterol-rich lipid domain. Figure 7 presents
a schematic representation (center) of correlated EGFRs
(green) in a cholesterol-rich (yellow) lipid domain. With-
out membrane cholesterol (right schematic of Fig. 7), a
deterministic dimerization interaction dominates, which
causes the V (Rτ 2) value to be increased to higher than 10
as shown in Fig. 6f. Liganded EGFR can also be attracted
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Fig. 7 Schematic representation of correlated EGFRs (green) in a cholesterol (yellow) enriched lipid domain (center) and in a cholesterol-depleted
nonraft lipid domain (right), drawn to illustrate the conclusion of this study. The red object on EGFR denotes the EGF ligand. Cholesterol molecules
increase receptor-receptor interaction and thus promote the stability of correlatively moving EGFRs
to an existing lipid domain. As pointed out above that
coupling between inner and outer leaves of an asymmet-
ric lipid bilayer could produce inhomogeneities of lipid
phases with a nonzero curvature [37]. Such membrane
deformations could affect the movements of liganded
receptors with the deformed lipids. Because the three cell
lines used for this study are quite diverse, our results may
be useful to shed light on the mechanism of cholesterol-
mediated interaction between activated receptors in live
cells.
Conclusions
In summary, we studied single-molecule optical trajec-
tories of EGFRs moving in the plasma membranes of
two cancerous cell lines (A431 and HeLa) and one nor-
mal epithelial cell line (MCF-12A). A stochastic model
of single-molecule optical data, developed in our previ-
ous study [22], was used to analyze and identify critical
information from single-molecule trajectories. We dis-
closed that EGFRs at rest in the three cell lines are located
outside the cholesterol-rich lipid domains; EGF binding
induces the receptors to move into the cholesterol-rich
lipid domains. The liganded receptors diffusing in prox-
imity in the plasma membrane interact with each other
that causes the receptors tomove correlatively. Membrane
cholesterol was found to considerably affect the correlated
motion of activated EGFRs. Our single-molecule tracking
results reveal the vital role of membrane cholesterol in
mediating the interaction between liganded receptors in
the three cell lines under study. Because receptor dimer-
ization is a common process for signal transduction, our
results can shed light on the way in which cholesterol
molecules regulate receptor-receptor interactions in the
plasma membranes of live cells.
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